In another new UAB study, 15 minutes of stimulation before a 45-minute session with a physical therapist made lasting ...

Brain-computer interfaces offer new hope to people with disabilities. With big tech rushing in to invest, the boundaries are ...

Novocure (NASDAQ: NVCR) today reported financial results for the first quarter that ended March 31, 2026. Novocure is a ...

When a top journal like PNAS (Procedings of the Nationsl Academy of Science) publishes an article entitled "What’s the science behind acupuncture?", I must take notice. Here is my take on the (sadly d ...

The company will use the funds to accelerate its clinical programs and prepare for commercialization of its neuromodulation ...

It may not look like much, but for 10-year-old Mae Lilley, a laser treatment is part of what finally brought relief after ...

Nervonik has secured $52.5m in Series B financing aimed at advancing its peripheral nerve stimulation (PNS) system.

Nervonik Inc. raised $52.5 million in a series B financing round for its peripheral nerve stimulation (PNS) system designed ...

Nervonik raises $52.5M in Series B funding to advance its peripheral nerve stimulation technology and expand innovative ...

Nervonik announced today that it closed an oversubscribed Series B financing round worth proceeds of $52.5 million.

Nervonik, Inc., a clinical-stage medical device company developing next-generation peripheral nerve stimulation (PNS) technologies, today announced the closing of an oversubscribed $52.5 million ...

Could tickling your ears with electricity really boost your V02 max? Simon Fellows investigates the strange but promising ...